A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Clinical trial NCT07323654 · RECRUITING
Trial details
- NCT number
- NCT07323654
- Sponsor
- Kymera Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-28
- Primary completion
- 2027-12-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.